Multiplexed analyses of test samples
US-9404919-B2 · Aug 2, 2016 · US
US11111495B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11111495-B2 |
| Application number | US-201916414026-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 16, 2019 |
| Priority date | Jan 16, 2007 |
| Publication date | Sep 7, 2021 |
| Grant date | Sep 7, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure describes improved SELEX methods for producing aptamers that are capable of binding to target molecules and improved photoSELEX methods for producing photoreactive aptamers that are capable of both binding and covalently crosslinking to target molecules. Specifically, the present disclosure describes methods for producing aptamers and photoaptamers having slower dissociation rate constants than are obtained using prior SELEX and photoSELEX methods. The disclosure further describes aptamers and photoaptamers having slower dissociation rate constants than those obtained using prior methods. In addition, the disclosure describes aptamer constructs that include a variety of functionalities, including a cleavable element, a detection element, and a capture or immobilization element.
Opening claim text (preview).
What is claimed is: 1. A non-covalent complex of an aptamer and a target molecule, wherein the aptamer comprises at least one 5-position modified pyrimidine having a hydrophobic group attached via a linker to the 5-position of the pyrimidine, and wherein the aptamer has binding affinity for the target molecule. 2. The non-covalent complex of claim 1 , wherein the hydrophobic group is selected from the group consisting of a benzyl, iso-butyl, indole and naphthyl. 3. The non-covalent complex of claim 1 , wherein the 5-position modified pyrimidine is a 5-position modified uridine or cytosine. 4. The non-covalent complex of claim 1 , wherein the target molecule is a protein or peptide. 5. The non-covalent complex of claim 1 , wherein the linker is selected from the group of linkers consisting of:
characterised by the detection means (C12Q1/6804 takes precedence) · CPC title
Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith {; Nucleic acids binding to non-nucleic acids, e.g. aptamers} · CPC title
involving labelled substances (G01N33/53 takes precedence) · CPC title
Phosphoramidates · CPC title
SELEX · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.